Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Waukegan › NPI 1619371267
NP / PA

Gill, Mohanjit

Gill, Mohanjit was paid $1.15M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.

33Billing provider infoGILL, MOHANJIT
WAUKEGAN, IL 60085
33aNPI1619371267assigned 10/10/2014
33bProvider typeNurse Practitioner
28Total paid$1.15M
24GClaims28,435
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Nurse Practitioner providers in Illinois

Rank by total paid#4 of 1,687
Median peer was paid$22K
This provider vs. median52×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,003$74K
20191,281$49K
20201,320$60K
20211,307$48K
20221,158$48K
20234,991$199K
2024incomplete16,375$674K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 4,581 4,227 $165K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 12% 2,538 2,136 $137K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 11% 2,461 2,172 $129K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 8.4% 1,391 1,159 $97K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 6.2% 403 337 $72K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 6.0% 1,388 1,159 $69K
87634 6.0% 1,370 1,153 $69K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.5% 789 684 $52K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 4.5% 1,363 1,163 $51K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 4.2% 1,408 1,185 $48K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 3.9% 872 754 $45K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2.8% 1,064 892 $33K
38 more codes
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.7% 496 $31K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.7% 496 $31K
87563 1.5% 464 $17K
99214 Doctor's office visit, returning patient (more involved) 1.4% 166 $16K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.2% 513 $14K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 435 $11K
94760 <1% 2,607 $8K
87511 <1% 217 $8K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 149 $7K
99204 Doctor's office visit, new patient (more involved) <1% 49 $4K
80074 <1% 118 $4K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 36 $4K
99384 <1% 32 $3K
81025 <1% 575 $3K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 128 $3K
87641 <1% 65 $2K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 29 $2K
87500 <1% 70 $2K
87640 <1% 58 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 26 $2K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 19 $2K
99383 <1% 14 $1K
81002 <1% 490 $1K
81003 <1% 453 $952.11
86696 <1% 45 $842.58
87480 <1% 35 $701.75
87510 <1% 35 $701.75
86695 <1% 45 $589.64
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 17 $425.00
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 44 $356.70
80053 Comprehensive metabolic panel <1% 36 $326.74
86592 <1% 60 $231.89
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 16 $166.77
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 23 $132.02
82947 <1% 14 $51.57
G8428 Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given 0% 461 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 237 $0.00
G8783 Normal blood pressure reading documented, follow-up not required 0% 34 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.